Cardiff Oncology, Inc. (CRDF) vs Korro Bio, Inc. (KRRO)

A side-by-side comparison of Cardiff Oncology, Inc. and Korro Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRDF vs KRRO

growth of $100 · dividends reinvested · last 7y
CRDF -14.9% (-2.3%/yr)KRRO -98.5% (-45.4%/yr)CRDF compounded faster over this window
Log scale — wide-divergence pair
01101001k10kStart $100202120232025$85$1
CRDF KRRO

CRDF vs KRRO: by the numbers

  • •KRRO is the larger company ($98M vs $86M market cap).
  • •Both run net losses; KRRO's is the smaller (-4477.08% vs -7884.06% net margin).
  • •CRDF grew revenue faster over the past five years (5.15% vs -41.67% CAGR).

Metrics side by side

Valuation

MetricCRDFKRRO
P/S ratio168.4141.30
P/B ratio3.220.95

Profitability

MetricCRDFKRRO
Gross margin100.00%33.04%
Operating margin-8256.32%-1366.43%
Net margin-7884.06%-4477.08%
ROE-150.95%-103.31%
ROIC-159.30%-50.17%

Growth (annualized)

MetricCRDFKRRO
Revenue CAGR (5Y)5.15%-41.67%
Total return CAGR (5Y)-30.36%-50.72%

Frequently asked

Which has grown faster, CRDF or KRRO?
Over the past five years, CRDF grew revenue faster — CRDF at a 5.15% CAGR versus KRRO at -41.67%.
How have CRDF and KRRO total returns compared?
Over the past 5 years, CRDF delivered -30.36% and KRRO delivered -50.72% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.